Without NAGS, there is no activity of CPS1 and, hence, clinical and biochemical features of NAGSD are indistinguishable from CPS1D, with increased plasma ammonia and glutamine, decreased plasma citrulline, and normal to low levels of urinary orotic acid. The gene discussed is NAGS; the disease is carbamoyl phosphate synthetase I deficiency disease.